<DOC>
	<DOCNO>NCT00041496</DOCNO>
	<brief_summary>The purpose study determine whether study drug effective preventing recurrence atrial fibrillation ( abnormal heart rhythm ) .</brief_summary>
	<brief_title>Prevention Of Recurrence Of Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Symptomatic persistent atrial fibrillation require DC cardioversion . Duration AF &gt; 48 hr . &lt; 6 month Concomitant Class I and/or III antiarrhythmic drug . Amiodarone treatment within 3 month study . Other inclusion exclusion criterion determine physician study sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>symptomatic atrial fibrillation</keyword>
	<keyword>persistent atrial fibrillation</keyword>
</DOC>